People: Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

2.79NOK
19 Dec 2014
Price Change (% chg)

kr0.00 (+0.00%)
Prev Close
kr2.79
Open
kr2.89
Day's High
kr2.89
Day's Low
kr2.71
Volume
84,322
Avg. Vol
246,510
52-wk High
kr5.44
52-wk Low
kr2.51

Search Stocks

Framroze, Bomi 

Brief Biography

Dr. Bomi Framroze has served as Chief Scientific Officer of Hofseth Biocare ASA since 2010. Dr. Framroze is a Discovery scientist with over 40 worldwide patents and publications in Life Science and Chemical software research. He has been an Associate Director of Chemical Discovery at American Cyanamid, an Executive Director at Gharda Chemicals Ltd. and was Founder/CSO of Row2Technologies Inc. Since 2004 he has been carrying out Discovery research in process technologies, biochemistry and marine ingredients.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kjetil Olsen

441,000

Jon Odegard

1,284,000

Oystein Omvik

1,162,000

Bomi Framroze

--

Matt Mixter

--

Tim Avila

--
As Of 30 Dec 2013
Search Stocks